Skip to content
← Back to this collection

PUBLICATIONS · 30345884

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2018 Dec 27
First author
Moore K

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2018 Dec;15(12):725. doi: 10.1038/s41571-018-0126-8.
    note
    Source null
    related pmid
    30410080
    relationship
    Comment in
  2. citation
    N Engl J Med. 2018 Dec 27;379(26):2567-2568. doi: 10.1056/NEJMe1812644.
    note
    Source null
    related pmid
    30586521
    relationship
    Comment in

Authors and identifiers

  1. name
    Moore K
    type
    Author
  2. name
    Colombo N
    type
    Author
  3. name
    Scambia G
    type
    Author
  4. name
    Kim BG
    type
    Author
  5. name
    Oaknin A
    type
    Author
  6. name
    Friedlander M
    type
    Author
  7. name
    Lisyanskaya A
    type
    Author
  8. name
    Floquet A
    type
    Author
  9. name
    Leary A
    type
    Author
  10. name
    Sonke GS
    type
    Author
  11. name
    Gourley C
    type
    Author
  12. name
    Banerjee S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Moore K
    type
    Author
  2. name
    Colombo N
    type
    Author
  3. name
    Scambia G
    type
    Author
  4. name
    Kim BG
    type
    Author
  5. name
    Oaknin A
    type
    Author
  6. name
    Friedlander M
    type
    Author
  7. name
    Lisyanskaya A
    type
    Author
  8. name
    Floquet A
    type
    Author
  9. name
    Leary A
    type
    Author
  10. name
    Sonke GS
    type
    Author
  11. name
    Gourley C
    type
    Author
  12. name
    Banerjee S
    type
    Author
bibliography ids
  1. nci-bib-a9541967740a5dd008b3793d
book metadata
content sha256
16099fba8aff65f0cc9a9d414eb5c1e305fea4230a6e447904604b0af068b94f
document type
citation
dois
  1. 10.1056/NEJMoa1810858
electronic publication date
display
2018 Oct 21
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:30345884
immutable id
pubmed:30345884@16099fba8aff65f0cc9a9d414eb5c1e305fea4230a6e447904604b0af068b94f
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
26
name
The New England journal of medicine
nlm unique id
0255562
pages
2495-2505
volume
379
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2018 Dec;15(12):725. doi: 10.1038/s41571-018-0126-8.
    note
    Source null
    related pmid
    30410080
    relationship
    Comment in
  2. citation
    N Engl J Med. 2018 Dec 27;379(26):2567-2568. doi: 10.1056/NEJMe1812644.
    note
    Source null
    related pmid
    30586521
    relationship
    Comment in
outcomes validated
false
pmid
30345884
provenance
batch id
438b2803888025c6cf56
provider
NCBI PubMed ESummary
record sha256
4ff942e536080570bbe9385ea8ed5b560419d34e49467a9cb1e1516c0dba01ce
response sha256
0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
retrieved at
2026-09-09T23:47:36.359220+00:00
publication date
display
2018 Dec 27
precision
day
year
2018
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30345884/
title
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.

Preserved source evidence · Not medical advice